Shrooms in the News Vol. 11: All the Guided Psilocybin Therapy Headlines Fit to Print

Pop on some sweatpants and go out to the stoop—the latest edition of Shrooms in the News has officially dropped. This month, we celebrate inroads made against Lyme disease, a federal grant that will allow Oregon Health and Science University to more efficiently track patient outcomes. And…we gratefully acknowledge national news coverage despite some confirmation bias, while raising our eyebrows at new research that isolates psilocin and wants us to trip without tripping.

Study Reveals Significant Progress for Patients with Lyme Disease

A small study (20 participants) shows a significant decrease of negative symptoms associated with chronic Lyme Disease, even 6 months after their last psychedelic session. 

3.3 Million in Federal Funding for Local University to Quantify Outcomes of Psilocybin Therapy in Oregon

With a focus on substance-use, this injection of capital will help us more comprehensively understand the lasting benefit of psilocybin-assisted therapy in Oregon.

Tech Startups Want Us To Trip Without the Trip

Backed by private investors, a study in mice reveals that a new synthetic version of psilocin may allow users to reap the benefits of magic mushrooms without the trip itself. 

National Coverage of Psilocybin Therapy from Science Friday

As part of their mental health spotlight, Science Friday aired a basic conversation with a journalist in Colorado.